Everett Magann
Concepts (662)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy | 233 | 2024 | 2468 | 11.090 |
Why?
| Pregnancy Complications | 42 | 2024 | 363 | 9.920 |
Why?
| Amniotic Fluid | 33 | 2023 | 70 | 8.950 |
Why?
| Pregnancy Outcome | 64 | 2024 | 205 | 8.470 |
Why?
| Ultrasonography, Prenatal | 40 | 2023 | 160 | 7.910 |
Why?
| Obstetrics | 20 | 2022 | 86 | 5.440 |
Why?
| Premature Birth | 25 | 2023 | 143 | 5.390 |
Why?
| Oligohydramnios | 25 | 2023 | 41 | 5.180 |
Why?
| Cesarean Section | 42 | 2024 | 159 | 4.950 |
Why?
| Delivery, Obstetric | 32 | 2024 | 109 | 4.690 |
Why?
| Female | 251 | 2024 | 26576 | 4.480 |
Why?
| Gestational Age | 48 | 2024 | 386 | 3.800 |
Why?
| Prenatal Care | 12 | 2023 | 106 | 3.500 |
Why?
| Telemedicine | 12 | 2023 | 465 | 3.390 |
Why?
| Postpartum Hemorrhage | 12 | 2018 | 34 | 3.270 |
Why?
| Labor Stage, Third | 9 | 2018 | 19 | 3.220 |
Why?
| Humans | 257 | 2024 | 49929 | 3.200 |
Why?
| Polyhydramnios | 13 | 2019 | 24 | 3.020 |
Why?
| Infant, Newborn | 75 | 2024 | 2729 | 2.900 |
Why?
| Fetal Membranes, Premature Rupture | 7 | 2023 | 22 | 2.770 |
Why?
| Adult | 138 | 2024 | 13356 | 2.710 |
Why?
| Placenta | 8 | 2022 | 129 | 2.670 |
Why?
| Uterine Rupture | 5 | 2023 | 10 | 2.640 |
Why?
| Pre-Eclampsia | 14 | 2024 | 42 | 2.630 |
Why?
| Obstetric Labor Complications | 12 | 2020 | 25 | 2.590 |
Why?
| Hypertension, Pregnancy-Induced | 6 | 2024 | 14 | 2.460 |
Why?
| Fetal Diseases | 7 | 2022 | 60 | 2.380 |
Why?
| Pregnancy, High-Risk | 10 | 2021 | 54 | 1.900 |
Why?
| Diabetes, Gestational | 6 | 2024 | 51 | 1.840 |
Why?
| Military Personnel | 10 | 2013 | 156 | 1.710 |
Why?
| Pregnancy Complications, Neoplastic | 3 | 2024 | 24 | 1.710 |
Why?
| Birth Weight | 14 | 2020 | 104 | 1.690 |
Why?
| Parturition | 8 | 2023 | 49 | 1.690 |
Why?
| Gynecology | 8 | 2022 | 49 | 1.580 |
Why?
| Labor, Obstetric | 11 | 2023 | 39 | 1.570 |
Why?
| Labor, Induced | 11 | 2020 | 16 | 1.520 |
Why?
| Risk Factors | 35 | 2023 | 3605 | 1.520 |
Why?
| Infant, Small for Gestational Age | 11 | 2024 | 32 | 1.450 |
Why?
| Fetal Growth Retardation | 10 | 2016 | 37 | 1.450 |
Why?
| Hypertension | 8 | 2024 | 531 | 1.430 |
Why?
| Pregnancy Complications, Cardiovascular | 6 | 2024 | 29 | 1.430 |
Why?
| Pregnancy, Abdominal | 3 | 2015 | 10 | 1.370 |
Why?
| Uterine Diseases | 4 | 2020 | 10 | 1.320 |
Why?
| Surgical Wound Dehiscence | 2 | 2021 | 18 | 1.320 |
Why?
| Prospective Studies | 35 | 2024 | 2345 | 1.280 |
Why?
| Vaginal Birth after Cesarean | 4 | 2023 | 7 | 1.270 |
Why?
| Rural Health Services | 4 | 2016 | 168 | 1.270 |
Why?
| Hemorrhage | 5 | 2023 | 194 | 1.270 |
Why?
| Retrospective Studies | 46 | 2023 | 6124 | 1.240 |
Why?
| Congenital Abnormalities | 5 | 2021 | 112 | 1.200 |
Why?
| Peripartum Period | 4 | 2022 | 15 | 1.190 |
Why?
| Abortion, Spontaneous | 2 | 2022 | 16 | 1.180 |
Why?
| Young Adult | 37 | 2024 | 4031 | 1.170 |
Why?
| Pregnancy Complications, Infectious | 6 | 2021 | 74 | 1.170 |
Why?
| Postpartum Period | 10 | 2024 | 104 | 1.140 |
Why?
| Pregnancy Trimester, Third | 11 | 2022 | 56 | 1.140 |
Why?
| Twins | 7 | 2014 | 21 | 1.130 |
Why?
| Obesity, Morbid | 2 | 2018 | 74 | 1.130 |
Why?
| Obstetric Labor, Premature | 9 | 2016 | 29 | 1.090 |
Why?
| Fetal Weight | 6 | 2014 | 10 | 1.090 |
Why?
| Pregnancy Complications, Hematologic | 5 | 2021 | 14 | 1.020 |
Why?
| Ultrasonography | 13 | 2023 | 429 | 1.020 |
Why?
| Dye Dilution Technique | 5 | 2014 | 14 | 0.980 |
Why?
| Dystocia | 8 | 2014 | 9 | 0.970 |
Why?
| Ultrasonography, Doppler, Color | 4 | 2019 | 31 | 0.970 |
Why?
| Referral and Consultation | 5 | 2015 | 285 | 0.970 |
Why?
| Fetal Death | 5 | 2022 | 21 | 0.950 |
Why?
| Body Mass Index | 12 | 2020 | 648 | 0.930 |
Why?
| Fetal Macrosomia | 9 | 2015 | 17 | 0.920 |
Why?
| Fetus | 4 | 2020 | 213 | 0.910 |
Why?
| Uterine Prolapse | 1 | 2023 | 3 | 0.900 |
Why?
| Morbidity | 4 | 2023 | 128 | 0.890 |
Why?
| Parity | 14 | 2020 | 43 | 0.890 |
Why?
| Uterus | 6 | 2023 | 87 | 0.880 |
Why?
| Pelvic Girdle Pain | 1 | 2023 | 2 | 0.880 |
Why?
| Esophageal Neoplasms | 1 | 2024 | 104 | 0.870 |
Why?
| Antihypertensive Agents | 4 | 2024 | 124 | 0.870 |
Why?
| Health Services Accessibility | 4 | 2021 | 417 | 0.850 |
Why?
| Adrenal Gland Diseases | 1 | 2023 | 8 | 0.850 |
Why?
| Surgical Wound Infection | 5 | 2017 | 114 | 0.840 |
Why?
| Adrenal Insufficiency | 1 | 2023 | 18 | 0.840 |
Why?
| Adenomyosis | 1 | 2022 | 1 | 0.830 |
Why?
| Domestic Violence | 3 | 2012 | 20 | 0.820 |
Why?
| Maternal Death | 1 | 2022 | 7 | 0.810 |
Why?
| Maternal Mortality | 5 | 2020 | 24 | 0.810 |
Why?
| Rural Population | 4 | 2022 | 549 | 0.810 |
Why?
| Cystitis | 1 | 2022 | 17 | 0.800 |
Why?
| Health Status Disparities | 2 | 2022 | 196 | 0.790 |
Why?
| Hyperparathyroidism | 1 | 2022 | 31 | 0.780 |
Why?
| Arkansas | 14 | 2022 | 1990 | 0.770 |
Why?
| Postmenopause | 1 | 2022 | 76 | 0.770 |
Why?
| Time Factors | 21 | 2024 | 2891 | 0.760 |
Why?
| Privacy | 1 | 2021 | 16 | 0.760 |
Why?
| Stomach Neoplasms | 1 | 2024 | 187 | 0.760 |
Why?
| Fetal Distress | 10 | 2020 | 11 | 0.750 |
Why?
| Communication Barriers | 1 | 2021 | 32 | 0.740 |
Why?
| Spinal Cord Injuries | 1 | 2021 | 53 | 0.720 |
Why?
| Practice Guidelines as Topic | 10 | 2020 | 458 | 0.720 |
Why?
| Respiratory Distress Syndrome, Newborn | 4 | 2017 | 48 | 0.710 |
Why?
| Torsion Abnormality | 1 | 2020 | 4 | 0.710 |
Why?
| Education, Medical | 1 | 2022 | 112 | 0.700 |
Why?
| Medically Underserved Area | 1 | 2020 | 42 | 0.690 |
Why?
| Umbilical Cord | 1 | 2020 | 34 | 0.690 |
Why?
| Carcinoma, Signet Ring Cell | 1 | 2019 | 14 | 0.680 |
Why?
| Placenta Diseases | 1 | 2019 | 14 | 0.680 |
Why?
| Adolescent | 31 | 2022 | 6417 | 0.670 |
Why?
| Adrenal Cortex Hormones | 2 | 2017 | 99 | 0.660 |
Why?
| Health Personnel | 2 | 2020 | 254 | 0.660 |
Why?
| Disease Management | 1 | 2021 | 175 | 0.660 |
Why?
| Simplexvirus | 1 | 2019 | 11 | 0.650 |
Why?
| Urinary Bladder Calculi | 1 | 2018 | 4 | 0.650 |
Why?
| Women's Health Services | 1 | 2019 | 15 | 0.650 |
Why?
| Herpes Simplex | 1 | 2019 | 21 | 0.640 |
Why?
| Military Medicine | 1 | 2019 | 22 | 0.640 |
Why?
| Lymphatic Metastasis | 1 | 2019 | 226 | 0.640 |
Why?
| Obesity | 5 | 2020 | 1096 | 0.640 |
Why?
| Fetal Mortality | 3 | 2015 | 7 | 0.630 |
Why?
| Uterine Inversion | 1 | 2018 | 1 | 0.630 |
Why?
| Stillbirth | 4 | 2022 | 29 | 0.620 |
Why?
| Cervical Ripening | 5 | 2016 | 6 | 0.620 |
Why?
| Intensive Care Units, Neonatal | 3 | 2015 | 118 | 0.610 |
Why?
| Women, Working | 2 | 2012 | 4 | 0.610 |
Why?
| Patient Satisfaction | 3 | 2023 | 278 | 0.590 |
Why?
| Diverticulum | 1 | 2017 | 21 | 0.580 |
Why?
| Internship and Residency | 2 | 2022 | 442 | 0.580 |
Why?
| Pregnancy, Twin | 2 | 2014 | 7 | 0.580 |
Why?
| Mass Screening | 4 | 2012 | 346 | 0.570 |
Why?
| Prenatal Diagnosis | 4 | 2022 | 104 | 0.570 |
Why?
| Stroke | 1 | 2022 | 478 | 0.560 |
Why?
| Predictive Value of Tests | 17 | 2019 | 907 | 0.560 |
Why?
| Uterine Retroversion | 1 | 2016 | 2 | 0.560 |
Why?
| Imaging, Three-Dimensional | 2 | 2019 | 152 | 0.560 |
Why?
| Blood Loss, Surgical | 3 | 2012 | 68 | 0.540 |
Why?
| Brachial Plexus Neuropathies | 2 | 2014 | 10 | 0.540 |
Why?
| Fish Products | 1 | 2016 | 2 | 0.540 |
Why?
| Pregnancy Complications, Parasitic | 1 | 2016 | 4 | 0.540 |
Why?
| Gastroschisis | 1 | 2016 | 38 | 0.530 |
Why?
| Pregnant Women | 4 | 2023 | 74 | 0.530 |
Why?
| Foodborne Diseases | 1 | 2016 | 12 | 0.530 |
Why?
| Genetic Counseling | 1 | 2016 | 40 | 0.530 |
Why?
| Heart Rate, Fetal | 10 | 2016 | 66 | 0.530 |
Why?
| Mississippi | 8 | 2015 | 84 | 0.510 |
Why?
| Genetic Testing | 1 | 2016 | 119 | 0.510 |
Why?
| Adenocarcinoma | 1 | 2019 | 402 | 0.510 |
Why?
| Death Certificates | 1 | 2015 | 17 | 0.500 |
Why?
| Birth Certificates | 1 | 2015 | 20 | 0.500 |
Why?
| Fetal Monitoring | 9 | 2013 | 39 | 0.500 |
Why?
| Tertiary Care Centers | 2 | 2015 | 76 | 0.500 |
Why?
| Cervix Uteri | 3 | 2011 | 42 | 0.500 |
Why?
| Odds Ratio | 9 | 2016 | 548 | 0.500 |
Why?
| Monitoring, Ambulatory | 1 | 2015 | 7 | 0.490 |
Why?
| Catheterization | 3 | 2011 | 100 | 0.490 |
Why?
| Randomized Controlled Trials as Topic | 8 | 2021 | 550 | 0.490 |
Why?
| Fetal Blood | 6 | 2010 | 66 | 0.490 |
Why?
| Magnetic Resonance Imaging | 4 | 2022 | 1526 | 0.480 |
Why?
| Chorionic Gonadotropin | 1 | 2014 | 18 | 0.480 |
Why?
| Pregnancy Trimester, First | 1 | 2014 | 22 | 0.470 |
Why?
| Fractures, Bone | 3 | 2014 | 105 | 0.470 |
Why?
| Automobile Driving | 1 | 2014 | 22 | 0.470 |
Why?
| Lung Neoplasms | 2 | 2019 | 602 | 0.460 |
Why?
| Tocolytic Agents | 5 | 2015 | 7 | 0.460 |
Why?
| Blood Pressure | 5 | 2024 | 519 | 0.450 |
Why?
| Posture | 2 | 2005 | 60 | 0.440 |
Why?
| Sensitivity and Specificity | 12 | 2017 | 858 | 0.440 |
Why?
| Algorithms | 4 | 2013 | 613 | 0.440 |
Why?
| Truth Disclosure | 1 | 2013 | 14 | 0.440 |
Why?
| Guideline Adherence | 3 | 2013 | 134 | 0.430 |
Why?
| Spouse Abuse | 2 | 2012 | 9 | 0.430 |
Why?
| Brain Injuries | 1 | 2014 | 159 | 0.410 |
Why?
| Apgar Score | 11 | 2018 | 25 | 0.410 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2013 | 105 | 0.410 |
Why?
| Ideal Body Weight | 1 | 2012 | 6 | 0.410 |
Why?
| Body Weights and Measures | 1 | 2012 | 17 | 0.410 |
Why?
| Magnesium Sulfate | 5 | 2016 | 10 | 0.400 |
Why?
| Rupture, Spontaneous | 2 | 2022 | 19 | 0.400 |
Why?
| Exercise | 2 | 2009 | 493 | 0.400 |
Why?
| Pilot Projects | 4 | 2022 | 702 | 0.390 |
Why?
| Hydroxyprogesterones | 3 | 2021 | 6 | 0.390 |
Why?
| Pregnancy Trimester, Second | 6 | 2020 | 20 | 0.390 |
Why?
| Gravidity | 3 | 2020 | 5 | 0.390 |
Why?
| Reproducibility of Results | 5 | 2021 | 1182 | 0.380 |
Why?
| Contraception | 1 | 2011 | 28 | 0.380 |
Why?
| Nifedipine | 3 | 2024 | 24 | 0.380 |
Why?
| Intrauterine Devices, Medicated | 1 | 2011 | 1 | 0.380 |
Why?
| Levonorgestrel | 1 | 2011 | 4 | 0.380 |
Why?
| Case-Control Studies | 10 | 2023 | 1129 | 0.370 |
Why?
| United States | 17 | 2023 | 4883 | 0.370 |
Why?
| Fluid Therapy | 2 | 2018 | 75 | 0.360 |
Why?
| Aerospace Medicine | 1 | 2010 | 3 | 0.360 |
Why?
| Multivariate Analysis | 5 | 2014 | 579 | 0.360 |
Why?
| Blood Transfusion | 3 | 2021 | 125 | 0.360 |
Why?
| Infant Mortality | 7 | 2013 | 57 | 0.360 |
Why?
| Tocolysis | 3 | 2015 | 3 | 0.350 |
Why?
| Pregnancy, Multiple | 2 | 2007 | 19 | 0.350 |
Why?
| Quality of Life | 3 | 2023 | 838 | 0.350 |
Why?
| HELLP Syndrome | 4 | 2007 | 4 | 0.350 |
Why?
| Prevalence | 7 | 2023 | 956 | 0.340 |
Why?
| Triage | 4 | 2024 | 61 | 0.340 |
Why?
| Treatment Outcome | 10 | 2024 | 5178 | 0.340 |
Why?
| Diagnosis, Differential | 5 | 2019 | 1037 | 0.340 |
Why?
| Battered Women | 1 | 2009 | 3 | 0.330 |
Why?
| Cohort Studies | 11 | 2021 | 1403 | 0.330 |
Why?
| Clinical Competence | 3 | 2022 | 396 | 0.330 |
Why?
| Acidosis | 3 | 2004 | 36 | 0.330 |
Why?
| Regression Analysis | 3 | 2018 | 385 | 0.330 |
Why?
| Middle Aged | 12 | 2022 | 12293 | 0.320 |
Why?
| Anemia, Sickle Cell | 2 | 2021 | 94 | 0.320 |
Why?
| Incidence | 7 | 2020 | 986 | 0.310 |
Why?
| Bibliometrics | 1 | 2008 | 16 | 0.310 |
Why?
| Publishing | 1 | 2008 | 38 | 0.310 |
Why?
| Hospitalization | 4 | 2024 | 663 | 0.310 |
Why?
| Chorioamnionitis | 4 | 2017 | 15 | 0.300 |
Why?
| Homocysteine | 1 | 2008 | 126 | 0.290 |
Why?
| Amnion | 3 | 2020 | 9 | 0.280 |
Why?
| Risk Assessment | 9 | 2019 | 1255 | 0.280 |
Why?
| Hospitals | 2 | 2020 | 172 | 0.270 |
Why?
| Hypercalcemia | 1 | 2006 | 33 | 0.270 |
Why?
| Remote Consultation | 2 | 2017 | 29 | 0.260 |
Why?
| Birth Injuries | 4 | 2013 | 10 | 0.260 |
Why?
| Umbilical Arteries | 5 | 2006 | 15 | 0.260 |
Why?
| Prognosis | 6 | 2018 | 1957 | 0.260 |
Why?
| Version, Fetal | 1 | 2005 | 1 | 0.260 |
Why?
| Oxytocin | 2 | 2005 | 18 | 0.260 |
Why?
| Lifting | 1 | 2005 | 2 | 0.260 |
Why?
| Renal Insufficiency | 1 | 2006 | 107 | 0.260 |
Why?
| Smoking | 4 | 2018 | 506 | 0.250 |
Why?
| Noise | 1 | 2005 | 38 | 0.250 |
Why?
| Brachial Plexus | 3 | 2013 | 11 | 0.240 |
Why?
| Placenta, Retained | 2 | 2016 | 3 | 0.240 |
Why?
| Cerebral Palsy | 2 | 2016 | 38 | 0.240 |
Why?
| Terbutaline | 2 | 2008 | 6 | 0.240 |
Why?
| Labetalol | 1 | 2024 | 2 | 0.240 |
Why?
| Chorion | 1 | 2004 | 1 | 0.230 |
Why?
| Noise, Occupational | 1 | 2024 | 3 | 0.230 |
Why?
| Coloring Agents | 1 | 2004 | 67 | 0.230 |
Why?
| Patient Care Team | 3 | 2021 | 259 | 0.230 |
Why?
| Home Infusion Therapy | 1 | 2003 | 1 | 0.220 |
Why?
| Urinary Tract Infections | 1 | 2023 | 51 | 0.220 |
Why?
| Intensive Care, Neonatal | 1 | 2003 | 22 | 0.220 |
Why?
| Medication Adherence | 1 | 2024 | 130 | 0.210 |
Why?
| Confidence Intervals | 5 | 2016 | 155 | 0.210 |
Why?
| Labor Stage, First | 4 | 2015 | 8 | 0.210 |
Why?
| Blood Volume | 2 | 2018 | 69 | 0.210 |
Why?
| Chorionic Villi | 2 | 2019 | 3 | 0.210 |
Why?
| Abortion, Therapeutic | 1 | 2002 | 3 | 0.210 |
Why?
| Logistic Models | 5 | 2011 | 896 | 0.210 |
Why?
| Pubic Symphysis | 2 | 2015 | 3 | 0.210 |
Why?
| Exudates and Transudates | 1 | 2002 | 4 | 0.210 |
Why?
| Hospitals, Military | 2 | 2014 | 7 | 0.210 |
Why?
| Intrauterine Devices | 2 | 2012 | 4 | 0.200 |
Why?
| Exercise Therapy | 1 | 2023 | 93 | 0.200 |
Why?
| Sutures | 1 | 2002 | 39 | 0.200 |
Why?
| Hospitals, Teaching | 2 | 2020 | 53 | 0.200 |
Why?
| Medicaid | 4 | 2023 | 255 | 0.200 |
Why?
| Embryo Implantation | 1 | 2002 | 7 | 0.200 |
Why?
| Chi-Square Distribution | 5 | 2012 | 275 | 0.200 |
Why?
| Acute Disease | 2 | 2022 | 367 | 0.200 |
Why?
| Male | 14 | 2022 | 25454 | 0.200 |
Why?
| Drainage | 1 | 2002 | 79 | 0.200 |
Why?
| Hematoma | 1 | 2002 | 64 | 0.200 |
Why?
| Uterine Hemorrhage | 1 | 2021 | 8 | 0.200 |
Why?
| Infant, Newborn, Diseases | 2 | 2013 | 56 | 0.190 |
Why?
| Emergency Service, Hospital | 2 | 2024 | 487 | 0.190 |
Why?
| Weight Gain | 3 | 2013 | 230 | 0.190 |
Why?
| Licensure | 1 | 2021 | 14 | 0.190 |
Why?
| Health Insurance Portability and Accountability Act | 1 | 2021 | 13 | 0.190 |
Why?
| Mothers | 2 | 2017 | 255 | 0.190 |
Why?
| Tissue Plasminogen Activator | 1 | 2022 | 110 | 0.190 |
Why?
| Reproductive Health | 1 | 2021 | 7 | 0.190 |
Why?
| Technology | 1 | 2021 | 20 | 0.190 |
Why?
| Risk Adjustment | 1 | 2021 | 16 | 0.190 |
Why?
| Maternal Age | 4 | 2015 | 41 | 0.190 |
Why?
| Progestins | 2 | 2012 | 9 | 0.190 |
Why?
| Fatal Outcome | 2 | 2019 | 194 | 0.180 |
Why?
| Hysterectomy | 4 | 2021 | 88 | 0.180 |
Why?
| Antithrombin Proteins | 1 | 2020 | 1 | 0.180 |
Why?
| Placenta Accreta | 1 | 2021 | 25 | 0.180 |
Why?
| Prolapse | 1 | 2020 | 6 | 0.180 |
Why?
| Puerperal Disorders | 2 | 2015 | 22 | 0.180 |
Why?
| Sleep | 1 | 2002 | 179 | 0.180 |
Why?
| Maternal Health Services | 1 | 2021 | 29 | 0.180 |
Why?
| Patient Care Planning | 1 | 2020 | 67 | 0.180 |
Why?
| Quality Improvement | 1 | 2022 | 205 | 0.170 |
Why?
| Surrogate Mothers | 1 | 2019 | 4 | 0.170 |
Why?
| Cross-Sectional Studies | 4 | 2017 | 1576 | 0.170 |
Why?
| Chest Pain | 1 | 2019 | 55 | 0.170 |
Why?
| ROC Curve | 6 | 2016 | 225 | 0.170 |
Why?
| Uterine Cervical Incompetence | 2 | 2011 | 2 | 0.170 |
Why?
| Misoprostol | 3 | 2016 | 5 | 0.170 |
Why?
| Oxytocics | 3 | 2016 | 6 | 0.170 |
Why?
| Cerclage, Cervical | 2 | 2011 | 8 | 0.170 |
Why?
| Dyspnea | 1 | 2019 | 74 | 0.170 |
Why?
| Mental Health Services | 1 | 2022 | 195 | 0.170 |
Why?
| Abdominal Pain | 1 | 2020 | 84 | 0.160 |
Why?
| Honduras | 1 | 2019 | 1 | 0.160 |
Why?
| Probability | 5 | 2008 | 163 | 0.160 |
Why?
| Guatemala | 1 | 2019 | 4 | 0.160 |
Why?
| Office Visits | 2 | 2013 | 41 | 0.160 |
Why?
| Colombia | 1 | 2019 | 14 | 0.160 |
Why?
| Contraception Behavior | 1 | 2019 | 10 | 0.160 |
Why?
| Acyclovir | 1 | 2019 | 9 | 0.160 |
Why?
| Lithotripsy, Laser | 1 | 2018 | 6 | 0.160 |
Why?
| Reference Values | 3 | 2019 | 302 | 0.160 |
Why?
| Tomography, X-Ray Computed | 3 | 2022 | 1153 | 0.160 |
Why?
| Critical Illness | 1 | 2021 | 297 | 0.160 |
Why?
| Australia | 3 | 2012 | 81 | 0.160 |
Why?
| Internet | 1 | 2021 | 261 | 0.160 |
Why?
| Child | 2 | 2023 | 6849 | 0.160 |
Why?
| Term Birth | 2 | 2008 | 15 | 0.160 |
Why?
| Obstetric Surgical Procedures | 1 | 2018 | 2 | 0.160 |
Why?
| Cell Adhesion Molecules | 1 | 2019 | 87 | 0.160 |
Why?
| Wounds and Injuries | 3 | 2009 | 281 | 0.160 |
Why?
| Vaginosis, Bacterial | 2 | 2011 | 8 | 0.150 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2010 | 483 | 0.150 |
Why?
| Fibronectins | 2 | 2011 | 38 | 0.150 |
Why?
| Fetal Development | 2 | 2016 | 59 | 0.150 |
Why?
| Age Factors | 3 | 2011 | 1092 | 0.150 |
Why?
| Early Diagnosis | 1 | 2018 | 87 | 0.150 |
Why?
| Postoperative Complications | 4 | 2017 | 1018 | 0.150 |
Why?
| Glucose Tolerance Test | 2 | 2010 | 56 | 0.150 |
Why?
| Heart Defects, Congenital | 1 | 2023 | 584 | 0.150 |
Why?
| Medical Records | 3 | 2014 | 85 | 0.150 |
Why?
| Aged | 3 | 2022 | 9449 | 0.150 |
Why?
| Chronic Disease | 3 | 2024 | 566 | 0.150 |
Why?
| Pyelonephritis | 1 | 2017 | 5 | 0.140 |
Why?
| Depression | 2 | 2017 | 571 | 0.140 |
Why?
| Antiviral Agents | 1 | 2019 | 168 | 0.140 |
Why?
| Actinomyces | 1 | 2017 | 9 | 0.140 |
Why?
| Actinomycosis | 1 | 2017 | 10 | 0.140 |
Why?
| Indomethacin | 2 | 2015 | 38 | 0.140 |
Why?
| Self-Injurious Behavior | 1 | 2017 | 28 | 0.140 |
Why?
| Malpractice | 2 | 2008 | 15 | 0.140 |
Why?
| Kidney | 1 | 2021 | 672 | 0.140 |
Why?
| Antioxidants | 1 | 2019 | 234 | 0.140 |
Why?
| Reactive Oxygen Species | 1 | 2019 | 405 | 0.140 |
Why?
| Telephone | 2 | 2017 | 70 | 0.140 |
Why?
| Brain Waves | 1 | 2016 | 18 | 0.140 |
Why?
| Symptom Assessment | 1 | 2016 | 32 | 0.140 |
Why?
| Patient Care Management | 1 | 2016 | 18 | 0.140 |
Why?
| Systole | 1 | 2016 | 71 | 0.140 |
Why?
| Puerperal Infection | 3 | 2005 | 5 | 0.140 |
Why?
| Biophysical Phenomena | 2 | 2014 | 18 | 0.130 |
Why?
| Intestinal Diseases, Parasitic | 1 | 2016 | 3 | 0.130 |
Why?
| Suicidal Ideation | 1 | 2017 | 98 | 0.130 |
Why?
| Socioeconomic Factors | 2 | 2016 | 584 | 0.130 |
Why?
| Colposcopy | 1 | 2016 | 18 | 0.130 |
Why?
| Pubic Symphysis Diastasis | 1 | 2015 | 2 | 0.130 |
Why?
| Hospitals, Community | 2 | 2014 | 19 | 0.130 |
Why?
| Humeral Fractures | 2 | 2013 | 8 | 0.130 |
Why?
| Clavicle | 2 | 2013 | 6 | 0.130 |
Why?
| Amniocentesis | 3 | 2004 | 6 | 0.130 |
Why?
| Hospitals, University | 2 | 2014 | 77 | 0.130 |
Why?
| Urologic Diseases | 1 | 2015 | 10 | 0.130 |
Why?
| Neuroprotective Agents | 1 | 2016 | 101 | 0.130 |
Why?
| Anticonvulsants | 1 | 2016 | 121 | 0.130 |
Why?
| Magnetoencephalography | 1 | 2016 | 117 | 0.120 |
Why?
| Hydrogen-Ion Concentration | 5 | 2011 | 168 | 0.120 |
Why?
| Endometritis | 3 | 2010 | 5 | 0.120 |
Why?
| Drug Implants | 2 | 2011 | 35 | 0.120 |
Why?
| Episiotomy | 1 | 2014 | 6 | 0.120 |
Why?
| Sheep | 1 | 2014 | 89 | 0.120 |
Why?
| Safety | 1 | 2015 | 77 | 0.120 |
Why?
| Southwestern United States | 1 | 2014 | 16 | 0.120 |
Why?
| Louisiana | 1 | 2014 | 39 | 0.120 |
Why?
| Pregnancy in Diabetics | 3 | 2010 | 27 | 0.120 |
Why?
| Southeastern United States | 1 | 2014 | 46 | 0.120 |
Why?
| Oxidative Stress | 1 | 2019 | 759 | 0.120 |
Why?
| Physician-Patient Relations | 2 | 2013 | 143 | 0.120 |
Why?
| Clinical Protocols | 2 | 2012 | 109 | 0.110 |
Why?
| Health Care Costs | 1 | 2015 | 168 | 0.110 |
Why?
| Academic Medical Centers | 1 | 2014 | 147 | 0.110 |
Why?
| Body Weight | 2 | 2013 | 512 | 0.110 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 269 | 0.110 |
Why?
| Insulin-Like Growth Factor II | 2 | 2010 | 19 | 0.110 |
Why?
| Healthy People Programs | 1 | 2013 | 4 | 0.110 |
Why?
| Brain Diseases | 2 | 2005 | 80 | 0.110 |
Why?
| Counseling | 1 | 2014 | 131 | 0.110 |
Why?
| Follow-Up Studies | 5 | 2017 | 2177 | 0.110 |
Why?
| Uterine Cervical Neoplasms | 1 | 2016 | 276 | 0.110 |
Why?
| Depression, Postpartum | 1 | 2013 | 42 | 0.110 |
Why?
| Image Enhancement | 1 | 2013 | 54 | 0.110 |
Why?
| Adnexa Uteri | 1 | 2012 | 1 | 0.110 |
Why?
| Digestive System | 1 | 2012 | 15 | 0.110 |
Why?
| Retroperitoneal Space | 1 | 2012 | 32 | 0.100 |
Why?
| Abdominal Wall | 1 | 2012 | 12 | 0.100 |
Why?
| Linear Models | 4 | 2021 | 274 | 0.100 |
Why?
| Peritoneum | 1 | 2012 | 17 | 0.100 |
Why?
| Trial of Labor | 4 | 2008 | 4 | 0.100 |
Why?
| Government Agencies | 1 | 2012 | 14 | 0.100 |
Why?
| Birth Rate | 1 | 2012 | 4 | 0.100 |
Why?
| Hemoglobins | 1 | 2013 | 106 | 0.100 |
Why?
| Mandatory Reporting | 1 | 2012 | 11 | 0.100 |
Why?
| Local Government | 1 | 2012 | 23 | 0.100 |
Why?
| Hematocrit | 1 | 2012 | 43 | 0.100 |
Why?
| Return to Work | 1 | 2012 | 11 | 0.100 |
Why?
| Attitude of Health Personnel | 3 | 2012 | 349 | 0.100 |
Why?
| Reference Standards | 1 | 2012 | 52 | 0.100 |
Why?
| Patient Care | 1 | 2012 | 57 | 0.100 |
Why?
| Motor Activity | 1 | 2013 | 221 | 0.100 |
Why?
| Administration, Oral | 3 | 2024 | 433 | 0.100 |
Why?
| Desogestrel | 1 | 2011 | 2 | 0.100 |
Why?
| Urination | 1 | 2011 | 19 | 0.100 |
Why?
| Infant | 4 | 2023 | 3575 | 0.100 |
Why?
| Contraceptive Agents, Female | 1 | 2011 | 5 | 0.100 |
Why?
| Osmolar Concentration | 1 | 2011 | 63 | 0.100 |
Why?
| Emotions | 1 | 2013 | 165 | 0.100 |
Why?
| Reproductive History | 1 | 2011 | 4 | 0.100 |
Why?
| Drug Eruptions | 1 | 2011 | 13 | 0.100 |
Why?
| Traction | 1 | 2011 | 7 | 0.100 |
Why?
| Personal Satisfaction | 1 | 2012 | 77 | 0.100 |
Why?
| Guidelines as Topic | 1 | 2012 | 110 | 0.100 |
Why?
| Surgical Sponges | 1 | 2011 | 6 | 0.100 |
Why?
| Labor Stage, Second | 2 | 2008 | 3 | 0.100 |
Why?
| Periodicals as Topic | 2 | 2010 | 57 | 0.100 |
Why?
| Deglutition | 1 | 2011 | 40 | 0.090 |
Why?
| Fetal Proteins | 1 | 2011 | 4 | 0.090 |
Why?
| Medical Errors | 1 | 2011 | 24 | 0.090 |
Why?
| 17-alpha-Hydroxyprogesterone | 1 | 2011 | 1 | 0.090 |
Why?
| Communication | 1 | 2013 | 247 | 0.090 |
Why?
| Energy Metabolism | 1 | 2013 | 282 | 0.090 |
Why?
| Weight-Bearing | 1 | 2011 | 46 | 0.090 |
Why?
| Metronidazole | 1 | 2011 | 27 | 0.090 |
Why?
| Receptor, IGF Type 2 | 1 | 2010 | 7 | 0.090 |
Why?
| Family Practice | 1 | 2012 | 101 | 0.090 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 488 | 0.090 |
Why?
| Appendicitis | 2 | 2009 | 62 | 0.090 |
Why?
| Hemodynamics | 1 | 2012 | 263 | 0.090 |
Why?
| Severity of Illness Index | 4 | 2010 | 953 | 0.090 |
Why?
| Qualitative Research | 1 | 2013 | 339 | 0.090 |
Why?
| RNA, Untranslated | 1 | 2010 | 14 | 0.090 |
Why?
| Hypersensitivity | 1 | 2011 | 76 | 0.090 |
Why?
| International Classification of Diseases | 1 | 2010 | 63 | 0.090 |
Why?
| Foreign Bodies | 1 | 2011 | 64 | 0.090 |
Why?
| Length of Stay | 3 | 2021 | 624 | 0.090 |
Why?
| Aviation | 1 | 2010 | 6 | 0.090 |
Why?
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2010 | 3 | 0.090 |
Why?
| Anti-Bacterial Agents | 3 | 2023 | 742 | 0.090 |
Why?
| Monitoring, Physiologic | 1 | 2011 | 127 | 0.090 |
Why?
| Anti-Infective Agents | 1 | 2011 | 95 | 0.090 |
Why?
| Pelvis | 2 | 2015 | 66 | 0.090 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2010 | 54 | 0.090 |
Why?
| Perinatal Care | 2 | 2020 | 26 | 0.080 |
Why?
| Cardiac Complexes, Premature | 1 | 2009 | 3 | 0.080 |
Why?
| Clothing | 1 | 2009 | 4 | 0.080 |
Why?
| Naval Medicine | 1 | 2009 | 4 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2010 | 68 | 0.080 |
Why?
| Exercise Tolerance | 1 | 2009 | 40 | 0.080 |
Why?
| Uterine Contraction | 2 | 2008 | 36 | 0.080 |
Why?
| Social Perception | 1 | 2009 | 27 | 0.080 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2009 | 2 | 0.080 |
Why?
| Marital Status | 1 | 2009 | 18 | 0.080 |
Why?
| Physicians | 2 | 2012 | 229 | 0.080 |
Why?
| Longitudinal Studies | 1 | 2011 | 693 | 0.080 |
Why?
| Physician's Role | 1 | 2009 | 48 | 0.080 |
Why?
| Research Design | 2 | 2008 | 344 | 0.080 |
Why?
| Medical History Taking | 1 | 2009 | 47 | 0.080 |
Why?
| Pregnancy, Prolonged | 1 | 2008 | 2 | 0.080 |
Why?
| Patient Preference | 1 | 2009 | 38 | 0.080 |
Why?
| Anthropometry | 2 | 2006 | 91 | 0.080 |
Why?
| Evidence-Based Medicine | 2 | 2009 | 247 | 0.080 |
Why?
| Surgical Procedures, Operative | 1 | 2009 | 66 | 0.080 |
Why?
| Attitude to Death | 1 | 2008 | 12 | 0.080 |
Why?
| Meta-Analysis as Topic | 1 | 2008 | 38 | 0.080 |
Why?
| Emergency Treatment | 2 | 2008 | 30 | 0.080 |
Why?
| Cardiotocography | 2 | 2005 | 8 | 0.080 |
Why?
| Pregnancy, Ectopic | 1 | 2008 | 9 | 0.080 |
Why?
| Asphyxia Neonatorum | 2 | 2010 | 8 | 0.080 |
Why?
| Brain | 1 | 2016 | 1310 | 0.080 |
Why?
| Fecal Incontinence | 1 | 2008 | 12 | 0.080 |
Why?
| Societies, Medical | 2 | 2006 | 177 | 0.080 |
Why?
| Constipation | 1 | 2008 | 33 | 0.070 |
Why?
| Genomic Imprinting | 1 | 2007 | 10 | 0.070 |
Why?
| Administration, Intravenous | 2 | 2020 | 70 | 0.070 |
Why?
| Perinatal Mortality | 2 | 2020 | 3 | 0.070 |
Why?
| Lung | 1 | 2011 | 501 | 0.070 |
Why?
| Double-Blind Method | 3 | 2020 | 679 | 0.070 |
Why?
| Nurse's Role | 1 | 2007 | 67 | 0.070 |
Why?
| Breast Feeding | 1 | 2009 | 187 | 0.070 |
Why?
| Body Size | 1 | 2007 | 27 | 0.070 |
Why?
| Forecasting | 1 | 2007 | 146 | 0.070 |
Why?
| Antacids | 1 | 2006 | 11 | 0.070 |
Why?
| Abdomen | 2 | 2006 | 75 | 0.070 |
Why?
| Workload | 1 | 2006 | 43 | 0.070 |
Why?
| Stress, Psychological | 1 | 2008 | 258 | 0.070 |
Why?
| Creatinine | 1 | 2006 | 140 | 0.070 |
Why?
| Ludwig's Angina | 1 | 2006 | 1 | 0.070 |
Why?
| Gastroesophageal Reflux | 1 | 2006 | 50 | 0.070 |
Why?
| Breech Presentation | 1 | 2005 | 1 | 0.070 |
Why?
| Mesothelioma | 1 | 2005 | 18 | 0.060 |
Why?
| Leptin | 1 | 2007 | 137 | 0.060 |
Why?
| Comorbidity | 2 | 2023 | 610 | 0.060 |
Why?
| Sepsis | 2 | 2009 | 220 | 0.060 |
Why?
| Hemostasis, Surgical | 1 | 2005 | 11 | 0.060 |
Why?
| Blood Gas Monitoring, Transcutaneous | 1 | 2005 | 7 | 0.060 |
Why?
| Uterine Neoplasms | 1 | 2005 | 60 | 0.060 |
Why?
| Acid-Base Imbalance | 1 | 2005 | 1 | 0.060 |
Why?
| Gene Frequency | 3 | 2010 | 96 | 0.060 |
Why?
| Analgesics | 1 | 2006 | 100 | 0.060 |
Why?
| Liver Neoplasms | 1 | 2009 | 329 | 0.060 |
Why?
| Insulin | 1 | 2007 | 453 | 0.060 |
Why?
| Patient Admission | 1 | 2005 | 73 | 0.060 |
Why?
| Pain, Postoperative | 1 | 2006 | 157 | 0.060 |
Why?
| Colonic Pseudo-Obstruction | 1 | 2004 | 3 | 0.060 |
Why?
| Infant, Premature, Diseases | 2 | 2020 | 93 | 0.060 |
Why?
| Hypoglycemia | 1 | 2005 | 52 | 0.060 |
Why?
| Antibiotic Prophylaxis | 1 | 2005 | 61 | 0.060 |
Why?
| Workplace | 1 | 2005 | 92 | 0.060 |
Why?
| Proteins | 1 | 2007 | 347 | 0.060 |
Why?
| Statistics, Nonparametric | 3 | 2011 | 193 | 0.060 |
Why?
| Calcium | 1 | 2006 | 401 | 0.060 |
Why?
| Pelvic Inflammatory Disease | 1 | 2004 | 8 | 0.060 |
Why?
| Thrombophlebitis | 1 | 2004 | 24 | 0.060 |
Why?
| Palliative Care | 1 | 2006 | 185 | 0.060 |
Why?
| Arterial Pressure | 1 | 2024 | 44 | 0.060 |
Why?
| Urogenital System | 1 | 2003 | 5 | 0.060 |
Why?
| Glycoproteins | 1 | 2004 | 115 | 0.060 |
Why?
| Pregnancy Trimesters | 2 | 2017 | 9 | 0.060 |
Why?
| Infusion Pumps | 1 | 2003 | 13 | 0.050 |
Why?
| Cesarean Section, Repeat | 1 | 2003 | 5 | 0.050 |
Why?
| Drug Administration Schedule | 3 | 2011 | 369 | 0.050 |
Why?
| Platelet Storage Pool Deficiency | 1 | 2003 | 1 | 0.050 |
Why?
| Injections, Subcutaneous | 1 | 2003 | 51 | 0.050 |
Why?
| Outpatients | 1 | 2004 | 112 | 0.050 |
Why?
| Propionates | 1 | 2003 | 22 | 0.050 |
Why?
| Emergency Medical Services | 1 | 2003 | 110 | 0.050 |
Why?
| Infusions, Intravenous | 1 | 2003 | 212 | 0.050 |
Why?
| Multiple Organ Failure | 1 | 2003 | 47 | 0.050 |
Why?
| Kidney Diseases | 1 | 2005 | 211 | 0.050 |
Why?
| Pregnancy Tests | 1 | 2002 | 2 | 0.050 |
Why?
| Autopsy | 1 | 2022 | 47 | 0.050 |
Why?
| Hospital Costs | 1 | 2003 | 72 | 0.050 |
Why?
| Heart Diseases | 1 | 2005 | 211 | 0.050 |
Why?
| Ovarian Diseases | 1 | 2002 | 2 | 0.050 |
Why?
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2002 | 6 | 0.050 |
Why?
| Tissue Expansion | 1 | 2002 | 4 | 0.050 |
Why?
| Dinoprostone | 1 | 2002 | 48 | 0.050 |
Why?
| Health Promotion | 1 | 2005 | 264 | 0.050 |
Why?
| Surgical Instruments | 1 | 2002 | 27 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 28 | 0.050 |
Why?
| Contrast Media | 1 | 2003 | 186 | 0.050 |
Why?
| Recurrence | 1 | 2003 | 658 | 0.050 |
Why?
| Patient Acceptance of Health Care | 1 | 2024 | 338 | 0.050 |
Why?
| Seizures | 1 | 2003 | 195 | 0.050 |
Why?
| Emergencies | 1 | 2021 | 84 | 0.050 |
Why?
| Intensive Care Units | 1 | 2021 | 223 | 0.040 |
Why?
| Reoperation | 1 | 2002 | 454 | 0.040 |
Why?
| Embryo Transfer | 1 | 2019 | 18 | 0.040 |
Why?
| Mental Health | 1 | 2022 | 218 | 0.040 |
Why?
| Animals | 1 | 2014 | 13100 | 0.040 |
Why?
| Risk | 2 | 2013 | 314 | 0.040 |
Why?
| Placentation | 1 | 2019 | 10 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2020 | 482 | 0.040 |
Why?
| Genotype | 2 | 2010 | 539 | 0.040 |
Why?
| Trophoblasts | 1 | 2019 | 29 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 211 | 0.040 |
Why?
| Treatment Failure | 2 | 2009 | 116 | 0.040 |
Why?
| Georgia | 1 | 2017 | 42 | 0.040 |
Why?
| APACHE | 1 | 2017 | 23 | 0.040 |
Why?
| Nicotine | 1 | 2018 | 182 | 0.040 |
Why?
| Betamethasone | 1 | 2016 | 3 | 0.030 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 180 | 0.030 |
Why?
| Transportation | 1 | 2016 | 31 | 0.030 |
Why?
| Psychiatric Status Rating Scales | 1 | 2017 | 322 | 0.030 |
Why?
| Psychometrics | 1 | 2017 | 226 | 0.030 |
Why?
| Cephalopelvic Disproportion | 1 | 2015 | 2 | 0.030 |
Why?
| Obstetrical Forceps | 1 | 2015 | 4 | 0.030 |
Why?
| Rupture | 1 | 2015 | 24 | 0.030 |
Why?
| Depressive Disorder, Major | 1 | 2017 | 150 | 0.030 |
Why?
| Fracture Fixation | 1 | 2015 | 16 | 0.030 |
Why?
| Urogenital Abnormalities | 1 | 2015 | 17 | 0.030 |
Why?
| Suppositories | 1 | 2015 | 1 | 0.030 |
Why?
| Program Evaluation | 1 | 2017 | 349 | 0.030 |
Why?
| Administration, Rectal | 1 | 2015 | 10 | 0.030 |
Why?
| Sexual Behavior | 1 | 2016 | 115 | 0.030 |
Why?
| Smoking Cessation | 1 | 2018 | 298 | 0.030 |
Why?
| Radiography | 1 | 2015 | 485 | 0.030 |
Why?
| Glucocorticoids | 1 | 2016 | 229 | 0.030 |
Why?
| South Carolina | 1 | 2014 | 21 | 0.030 |
Why?
| Dexamethasone | 1 | 2016 | 424 | 0.030 |
Why?
| Drug Administration Routes | 1 | 2013 | 11 | 0.030 |
Why?
| New Zealand | 1 | 2012 | 17 | 0.030 |
Why?
| Auscultation | 1 | 2012 | 9 | 0.030 |
Why?
| Health Care Surveys | 1 | 2012 | 174 | 0.030 |
Why?
| Canada | 1 | 2012 | 104 | 0.020 |
Why?
| Self Report | 1 | 2013 | 202 | 0.020 |
Why?
| Patient Safety | 1 | 2012 | 102 | 0.020 |
Why?
| Oximetry | 1 | 2012 | 65 | 0.020 |
Why?
| Vagina | 1 | 2011 | 44 | 0.020 |
Why?
| Area Under Curve | 1 | 2011 | 178 | 0.020 |
Why?
| Models, Statistical | 1 | 2012 | 225 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 234 | 0.020 |
Why?
| Chromogranins | 1 | 2010 | 5 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2010 | 13 | 0.020 |
Why?
| Inheritance Patterns | 1 | 2010 | 22 | 0.020 |
Why?
| Injections, Intramuscular | 1 | 2009 | 52 | 0.020 |
Why?
| Medical Informatics | 1 | 2010 | 48 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2010 | 159 | 0.020 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 53 | 0.020 |
Why?
| Appendectomy | 1 | 2009 | 32 | 0.020 |
Why?
| Administration, Intravaginal | 1 | 2008 | 4 | 0.020 |
Why?
| Virginia | 1 | 2008 | 19 | 0.020 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 108 | 0.020 |
Why?
| Flatulence | 1 | 2008 | 3 | 0.020 |
Why?
| Shoulder | 1 | 2008 | 18 | 0.020 |
Why?
| Observer Variation | 1 | 2008 | 136 | 0.020 |
Why?
| Rectum | 1 | 2008 | 52 | 0.020 |
Why?
| Linkage Disequilibrium | 1 | 2007 | 37 | 0.020 |
Why?
| Shoulder Fractures | 1 | 2007 | 7 | 0.020 |
Why?
| Pedigree | 1 | 2007 | 125 | 0.020 |
Why?
| Pelvic Floor | 1 | 2008 | 51 | 0.020 |
Why?
| Haplotypes | 1 | 2007 | 83 | 0.020 |
Why?
| Wisconsin | 1 | 2007 | 44 | 0.020 |
Why?
| Data Collection | 1 | 2008 | 283 | 0.020 |
Why?
| False Positive Reactions | 1 | 2007 | 60 | 0.020 |
Why?
| Obstetrics and Gynecology Department, Hospital | 1 | 2006 | 5 | 0.020 |
Why?
| Adaptation, Psychological | 1 | 2008 | 224 | 0.020 |
Why?
| Cytodiagnosis | 1 | 2005 | 42 | 0.020 |
Why?
| Registries | 1 | 2008 | 523 | 0.020 |
Why?
| Insurance, Liability | 1 | 2005 | 1 | 0.020 |
Why?
| Compensation and Redress | 1 | 2005 | 2 | 0.020 |
Why?
| Liability, Legal | 1 | 2005 | 12 | 0.020 |
Why?
| Diagnosis-Related Groups | 1 | 2005 | 18 | 0.020 |
Why?
| Mental Status Schedule | 1 | 2005 | 15 | 0.020 |
Why?
| Sex Characteristics | 1 | 2007 | 191 | 0.020 |
Why?
| Diastole | 1 | 2005 | 70 | 0.020 |
Why?
| Washington | 1 | 2005 | 47 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2005 | 100 | 0.020 |
Why?
| Pain Measurement | 1 | 2006 | 246 | 0.020 |
Why?
| Cecostomy | 1 | 2004 | 4 | 0.020 |
Why?
| Biophysics | 1 | 2004 | 15 | 0.010 |
Why?
| Phenotype | 1 | 2007 | 728 | 0.010 |
Why?
| Delivery Rooms | 1 | 2004 | 1 | 0.010 |
Why?
| Leukocyte Count | 1 | 2004 | 71 | 0.010 |
Why?
| Decision Making | 1 | 2006 | 273 | 0.010 |
Why?
| Maternal Welfare | 1 | 2004 | 8 | 0.010 |
Why?
| Wound Infection | 1 | 2004 | 27 | 0.010 |
Why?
| Databases, Factual | 1 | 2007 | 660 | 0.010 |
Why?
| Suicide | 1 | 2005 | 81 | 0.010 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2004 | 27 | 0.010 |
Why?
| Injury Severity Score | 1 | 2004 | 161 | 0.010 |
Why?
| Vancomycin | 1 | 2004 | 80 | 0.010 |
Why?
| Resuscitation | 1 | 2003 | 72 | 0.010 |
Why?
| Eclampsia | 1 | 2003 | 1 | 0.010 |
Why?
| Liver | 1 | 2009 | 1106 | 0.010 |
Why?
| Polyunsaturated Alkamides | 1 | 2003 | 3 | 0.010 |
Why?
| Heparin | 1 | 2004 | 92 | 0.010 |
Why?
| Fever | 1 | 2004 | 111 | 0.010 |
Why?
| Blood Gas Analysis | 1 | 2003 | 29 | 0.010 |
Why?
| Fibrinolytic Agents | 1 | 2004 | 125 | 0.010 |
Why?
| Neutrophils | 1 | 2004 | 148 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2006 | 1354 | 0.010 |
Why?
| Organ Size | 1 | 2003 | 223 | 0.010 |
Why?
| Hypothyroidism | 1 | 2003 | 54 | 0.010 |
Why?
| Tachycardia, Paroxysmal | 1 | 2002 | 8 | 0.010 |
Why?
| Gels | 1 | 2002 | 20 | 0.010 |
Why?
| Physical Examination | 1 | 2003 | 93 | 0.010 |
Why?
| Laparotomy | 1 | 2002 | 35 | 0.010 |
Why?
| Ovariectomy | 1 | 2002 | 113 | 0.010 |
Why?
| Infant, Premature | 1 | 2004 | 314 | 0.010 |
Why?
| Analgesics, Opioid | 1 | 2006 | 554 | 0.010 |
Why?
| Survival Analysis | 1 | 2002 | 670 | 0.010 |
Why?
| Asthma | 1 | 2003 | 282 | 0.010 |
Why?
|
|
Magann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|